Keywords
arterial hypertension
galectin-3
P-selectin
growth differentiation factor 15
How to Cite
Abstract
The association of galectin-3, P-selectin and growth differentiation factor-15 plasma levels with age and gender have determined in patients with arterial hypertension and diabetes mellitus type 2. No significant interaction was observed between the tested biomarkers and gender. According to the data of correlation and regression analyzes, a reliable interrelation between the levels of P-selletin and the growth differentiation factor-15 in the blood plasma of patients with age has been established.
References
Inflammation and atherosclerosis-revisited / S. Pant, A. Deshmukh, G. S. Gurumurthy [et al.] // J. Cardiovasc. Pharmacol. Ther. – 2014. – Vol. 19 (2). – P. 170–178.
Cardiovascular disease in Europe: epidemiological update 2016 / N. Townsend, L. Wilson, P. Bhatnagar [et al.] // Eur. Heart J. – 2016. – Nov. 7. – Vol. 37 (42). – P. 3232–3245.
. All-cause and cardiovascular mortality in middle-aged people with type 2 diabetes compared with people without diabetes in a large U.K. primary care database / K. S. Taylor, C. J. Farmer [et al] // Diabetes Care. – 2013. – Aug. – Vol. 36 (8). – P. 2366–2371.
Critical appraisal of inflammatory markers in cardiovascular risk stratification / M. Krintus, M. Kozinski, J. Kubica, G. Sypniewska // Crit. Rev. Clin. Lab. Sci. – 2014. – Oct. – Vol. 51 (5). – P. 263–279.
2013 ESH/ESC Guidelines for the management of arterial hypertension / G. Mancia, R. Fagard, K. Narkiewicz [et al] // Journal of Hypertension. – 2013. – Vol. 31. – P. 1281–1357.
Galectin-3 in heart failure: fn update of the last 3 years / C. Gehlken, N. Suthahar, W. C. Meijers, R. A. de Boer // Heart Fail. Clin. – 2018. – Jan. – Vol. 14 (1). – P. 75–92.
Novel biomarkers for cardiovascular risk prediction / Juan Wang, Guo-Juan Tan, Li-Na Han [et al.] // J. Geriatr. Cardiol. – 2017. – Feb. – Vol. 14 (2). – P. 135–150.